Screen More or Screen More Often? Using Mathematical Models to Inform Syphilis Control Strategies
Overview
Affiliations
Background: Syphilis incidence among men who have sex with men (MSM) continues to rise despite attempts to increase screening and treatment uptake. We examined the marginal effect of increased frequency versus increased coverage of screening on syphilis incidence in Toronto, Canada.
Methods: We developed an agent-based, network model of syphilis transmission, representing a core population of 2,000 high-risk MSM. Epidemiological and biological parameters were drawn from regional surveillance data and literature-derived estimates. The pre-intervention period of the model was calibrated using surveillance data to identify 1000 credible simulations per strategy. Evaluated strategies included: annual syphilis screening at baseline coverage, increased screening frequency at baseline coverage, and increased coverage of annual screening. Intervention impact was measured as annual prevalence of detected infectious cases and syphilis incidence per year over 10 years.
Results: Of the strategies evaluated, increasing the frequency of syphilis screening to every three months was most effective in reducing reported and incident syphilis infections. Increasing the fraction of individuals tested, without increasing test frequency, resulted a smaller decline in incidence, because reductions in infectious syphilis via treatment were counterbalanced by increased incident syphilis among individuals with prior latent syphilis. For an equivalent number of additional tests performed annually, increased test frequency was consistently more effective than improved coverage.
Conclusions: Strategies that focus on higher frequency of testing in smaller fractions of the population were more effective in reducing syphilis incidence in a simulated MSM population. The findings highlight how treatment-induced loss of immunity can create unexpected results in screening-based control strategies.
Urban N, Neidhart T, Grabmeier-Pfistershammer K, Touzeau-Roemer V, Schmidt K, Strassl R Wien Klin Wochenschr. 2025; .
PMID: 40025206 DOI: 10.1007/s00508-025-02499-6.
Ocular Syphilis in an HIV-Positive Transgender Female: A Case Report.
Roe K, Boney C, Mirza U, Parker R Cureus. 2024; 16(8):e66775.
PMID: 39268262 PMC: 11392505. DOI: 10.7759/cureus.66775.
Traeger M, Guy R, Taunton C, Chow E, Asselin J, Carter A Lancet Reg Health West Pac. 2024; 51:101175.
PMID: 39263009 PMC: 11387360. DOI: 10.1016/j.lanwpc.2024.101175.
Begum H, Gadient S, Bullard J, Gratrix J, Grennan T, Hatchette T Can Commun Dis Rep. 2024; 50(7-8):233-240.
PMID: 39170588 PMC: 11318798. DOI: 10.14745/ccdr.v50i78a01.
Xia Y, Caya C, Morin V, Singh A, Serhir B, Libman M Lancet Reg Health Am. 2024; 37:100845.
PMID: 39100242 PMC: 11295708. DOI: 10.1016/j.lana.2024.100845.